Unusual myeloma relapse after thalidomide therapy: the dark side of the moon?

Leuk Res. 2009 Sep;33(9):1164-5. doi: 10.1016/j.leukres.2009.04.020. Epub 2009 May 14.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunophenotyping
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Multiple Myeloma / pathology
  • Recurrence
  • Thalidomide / therapeutic use*

Substances

  • Thalidomide